PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-III Induction Study

Lilly Reports Results of Mirikizumab in P-III LUCENT-1 Induction Study for Ulcerative Colitis

Lilly Reports Results of Mirikizumab in P-III LUCENT-1 Induction Study for Ulcerative Colitis

March 17, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us